Live feed08:30:00·1hPRReleasevia QuantisnowAngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)ByQuantisnow·Wall Street's wire, on your screen.ANGO· AngioDynamics Inc.Health Care
